stroke/triglyceride

Länken sparas på Urklipp

Välj sorteringstyp

12 resultat

Composition comprising EPA and DHA triglycerides for parenteral administration

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. national stage application of International Application No. PCT/EP2015/051657, filed on Jan. 28, 2015, which claims priority to European Application No. 14152785.3, filed on Jan. 28, 2014. The contents of these previously filed

Method of lowering cholesterol and triglycerides by administering exendins

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The invention relates to the field of medicine, such as the use of exendins, exendin agonists, and exendin analog agonists to lower plasma lipid levels and improve cardiovascular health in patients. BACKGROUND OF THE INVENTION Research from experimental animals, laboratory

Cholesterol and triglyceride-modulating drugs and methods

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates generally to prevention and treatment of atherosclerosis, myocardial infarction and related conditions such as peripheral vascular disease and ischemic stroke, and specifically to drugs that increase levels of HDL. 2.

4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivative, and preparation method and uses thereof

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

CROSS-REFERENCE TO RELATED APPLICATIONS The present application is a national phase entry under 35 U.S.C. .sctn.371 of International Application No. PCT/CN2013/074739, filed on Apr. 25, 2013, published in Chinese, which claims priority from Chinese Patent Application No. 201210125154.4, filed Apr.

Method for the prediction of preeclampsia and other diseases

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention relates to methods for predicting and following illnesses. More particularly, the present invention relates to the diagnosis of preeclampsia and other diseases. BACKGROUND OF THE INVENTION Vascular disease is often related to the composition of blood

7-[(4'-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein B

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to compounds that inhibit the secretion of apolipoprotein B, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia,

7[4'-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Transmucosal delivery of tocotrienol

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a 371 U.S. National Stage of International Application No. PCT/AU2013/001310, filed Nov. 13, 2013. This application claims the benefit of Australian Patent Applications Nos. 2012904937, filed Nov. 13, 2012 and 2012905406, filed Dec. 11,

Tri-salt form of metformin

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

RELATED APPLICATION This application claims priority to U.S. Provisional Application No. 61/669,763, filed Jul. 10, 2012, the contents of which are incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION Diabetes mellitus has become pandemic and according to a forecast by the

Tri-salt form of metformin

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION Diabetes mellitus has become pandemic and according to a forecast by the World Health Organization, there will be a sharp increase in the number of diabetic patients by the year 2030. This is an ominous forecast, because managing the long-term complications of diabetes,

Tri-salt form of metformin

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Combinations of botanical extracts for promoting cardiovascular health

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention relates to medicinal compositions, particularly to combinations of botanical extracts for promoting cardiovascular health. BACKGROUND OF THE INVENTION Cardiovascular disease (CVD), including coronary heart disease, atherosclerosis, stroke, myocardial

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning